Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U3VH
|
|||
| Former ID |
DIB009880
|
|||
| Drug Name |
STEBVax
|
|||
| Synonyms |
Inactivated SEB vaccine (S aureus infection/toxic shock), USAMRIID; Inactivated staphylococcal enterotoxin B vaccine (S aureusinfection/toxic shock), USAMRIID
Click to Show/Hide
|
|||
| Indication | Endotoxic shock [ICD-11: 1G41; ICD-10: R57.2] | Phase 1 | [1] | |
| Toxic shock syndrome [ICD-11: 1B52; ICD-10: A48.3] | Phase 1 | [2] | ||
| Company |
US Army Medical Research Institute of Infectious Diseases
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00974935) Phase I STEBVax in Healthy Adults. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.